---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39734859.md"
description: "$Novo Nordisk AS(NVO.US)The only reason to still hold it is because it's cheap enough and has a high dividend, but from a product strength perspective, it's really shocking. The product is being completely suppressed and chased by Eli Lilly. Especially the oral weight-loss drugs; Eli Lilly's have better weight-loss effects and more flexible dosing methods. Is there really someone who would choose to endure needles when they have pills available?"
datetime: "2026-04-06T18:17:35.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39734859.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39734859.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39734859.md)
author: "[美股小学生:）](https://longbridge.com/en/profiles/21091736.md)"
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/topics/39734859.md) | [繁體中文](https://longbridge.com/zh-HK/topics/39734859.md)


# $Novo Nordisk AS(NVO.US)The only reason to still h…


### Related Stocks

- [Eli Lilly and Company (LLY.US)](https://longbridge.com/en/quote/LLY.US.md)
- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Comments (1)

- **不想成韭菜交易员7.26 · 2026-04-07T02:02:31.000Z**: Previously, those who used injections cannot switch to tablets; tablets are targeted at new weight loss groups.